The meta-analysis of Bethel et al. [94] evaluated CV outcomes for DM patients using GLP-1 RAs; four randomized trials (ELIXA, LEADER, SUSTAIN-6 and EXSCEL) were included. Here, GLP1R is linked to diabetes mellitus.